NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Blood Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Hyperglycemia



Glycosylated hemoglobin is linked to increased mortality in nondiabetic kidney disease



December 29th, 2005

Glycosylated hemoglobin is associated with an increased mortality in nondiabetic kidney disease patients.

According to recent research from the United States, "In the general population, hyperglycemia in the absence of diabetes may be associated with increased risk for mortality. Hyperglycemia is prevalent in chronic kidney disease; however, the relationship between glycosylated hemoglobin (HbA1c ) as a marker of chronic hyperglycemia and outcomes has not been studied in nondiabetic chronic kidney disease."

V. Menon and colleagues at Tufts University explained, "HbA1c was measured at baseline in the randomized cohort of the...


Source: Blood Weekly (2005-12-29)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login